The Kingsley Clinic

Flecainide Medication: Uses, Dosage, and Side Effects Explained

Summary of Key Points

Flecainide is a prescription medication used to treat specific types of irregular heartbeats, such as atrial fibrillation and ventricular tachycardia. It works by stabilizing the heart’s electrical signals, helping to maintain a regular rhythm. Flecainide is typically prescribed for patients who have not responded to other treatments. Always consult your healthcare provider before starting or adjusting your dose. If you need personalized care, consider scheduling a telemedicine appointment with us.

Names of Medication

US Brand Name: Tambocor

Generic Name: Flecainide

The generic name refers to the active ingredient in the medication, while the brand name is the marketed version. In this case, Flecainide is the generic name.

Pharmacologic Category

Class: Class I Antiarrhythmic

Other medications in this category include Quinidine, Procainamide, and Propafenone.

Flecainide Dosage

Flecainide is prescribed to treat various heart rhythm disorders. The dosage depends on the specific condition being treated. Always follow your doctor’s instructions and never adjust your dose without consulting a healthcare provider. If you need guidance, schedule a telemedicine appointment with one of our providers.

Flecainide for Atrial Fibrillation and Atrial Flutter

Initial dose: 50 mg orally every 12 hours. Your doctor may increase the dose based on your response, up to a maximum of 300 mg per day.

Flecainide for Ventricular Tachycardia

Initial dose: 100 mg orally every 12 hours. The dose may be adjusted by your doctor, up to a maximum of 400 mg per day.

Flecainide for Paroxysmal Supraventricular Tachycardia (PSVT)

Initial dose: 50 mg orally every 12 hours. Your doctor may increase the dose, but the maximum is 300 mg per day.

Flecainide for Wolff-Parkinson-White Syndrome

Initial dose: 100 mg orally every 12 hours. The dose may be adjusted by your doctor, up to a maximum of 400 mg per day.

Flecainide for Premature Ventricular Contractions

Initial dose: 100 mg orally every 12 hours. Your doctor may adjust the dose, up to a maximum of 400 mg per day.

Flecainide and Heart Failure

Flecainide is generally not recommended for patients with heart failure due to potential risks. Always consult your doctor for alternative treatments.

Flecainide for Tachyarrhythmias and Supraventricular Arrhythmias

Initial dose: 50 mg orally every 12 hours. The dose may be increased by your doctor, up to a maximum of 300 mg per day.

Flecainide for Cardiac Arrhythmias

Initial dose: 100 mg orally every 12 hours. Your doctor may adjust the dose, up to a maximum of 400 mg per day.

Dosage Forms and Strengths

Tablet: 50 mg, 100 mg, 150 mg

Administration Instructions for Flecainide

Take Flecainide exactly as prescribed by your doctor, typically twice a day, with or without food. Swallow the tablet whole with water. Do not crush or chew the tablet. If you miss a dose, take it as soon as you remember, but skip it if it’s almost time for your next dose. Never double up on doses. If you have any questions about how to take Flecainide, schedule a telemedicine visit with one of our providers.

Flecainide Side Effects and Adverse Reactions

Like all medications, Flecainide can cause side effects. Some are common, while others are rare but more serious. If you experience any side effects, contact your healthcare provider immediately.

Common Flecainide Side Effects:

  1. Dizziness: You may feel lightheaded or unsteady.
  2. Blurred Vision: Some patients report difficulty seeing clearly.
  3. Nausea: You may feel queasy or sick to your stomach.

Serious Flecainide Side Effects:

  1. Worsening Arrhythmias: Flecainide can sometimes cause new or worsening heart rhythm problems.
  2. Chest Pain: If you experience chest pain, seek medical attention immediately.
  3. Shortness of Breath: Difficulty breathing could indicate a serious reaction.

Contraindications for Flecainide

A contraindication is a specific situation or condition where a medication should not be used because it may be harmful. If you have any of the following conditions, Flecainide may not be safe for you. Always consult your healthcare provider before starting any new medication. If you’re unsure, schedule a telemedicine appointment with one of our providers.

  1. Structural heart disease: Flecainide is contraindicated in patients with structural heart disease, such as a history of heart attack or significant heart failure, as it can increase the risk of life-threatening arrhythmias.
  2. Cardiogenic shock: Flecainide should not be used in patients experiencing cardiogenic shock, a condition where the heart cannot pump enough blood to meet the body’s needs. Flecainide can worsen this condition by further reducing heart function.
  3. Second- or third-degree AV block (without a pacemaker): Flecainide can slow down electrical signals in the heart, worsening heart block in patients without a pacemaker.
  4. Brugada syndrome: This genetic condition affects the heart’s rhythm. Flecainide can exacerbate the abnormal rhythms seen in Brugada syndrome, increasing the risk of sudden cardiac death.
  5. Hypersensitivity to Flecainide: If you have had an allergic reaction to Flecainide in the past, you should not take this medication.

Drug to Drug Interactions

Flecainide can interact with other medications, potentially increasing side effects or reducing the effectiveness of either drug. It’s crucial to inform your healthcare provider about all the medications you’re taking, including over-the-counter drugs and supplements. Below are some common medications that may interact with Flecainide:

  1. Amiodarone (Pacerone, Cordarone): Combining Flecainide with Amiodarone can increase the risk of arrhythmias and other side effects.
  2. Digoxin (Lanoxin): Flecainide can raise Digoxin levels in the blood, which may lead to toxicity.
  3. Beta-blockers (e.g., Metoprolol, Atenolol): These medications can slow your heart rate, and when used with Flecainide, the effect may be intensified, potentially causing dangerously slow heart rates.
  4. Calcium channel blockers (e.g., Verapamil, Diltiazem): These drugs can also slow the heart rate, and when combined with Flecainide, the risk of bradycardia (slow heart rate) increases.
  5. Cimetidine (Tagamet): This medication can elevate Flecainide levels in the blood, increasing the risk of toxicity.
  6. Quinidine (Quinidex): Taking Quinidine with Flecainide can heighten the risk of arrhythmias.

Flecainide in Pregnancy

Is it safe to take Flecainide during pregnancy?

Flecainide is classified as a Category C medication for pregnancy, meaning there are no well-controlled studies in pregnant women, although animal studies have shown some risk to the fetus. Flecainide should only be used during pregnancy if the potential benefits outweigh the risks. If you are pregnant or planning to become pregnant, it’s important to discuss this with your healthcare provider to determine if Flecainide is the right choice for you. Our telemedicine providers are available to help guide you through this decision.

Flecainide while Breastfeeding

Is it safe to take Flecainide while breastfeeding?

Flecainide is excreted in breast milk, but its effects on a nursing infant are not well studied. If you are breastfeeding, it’s essential to weigh the potential risks and benefits with your healthcare provider. In some cases, alternative medications may be considered. You can schedule a telemedicine appointment with one of our providers to discuss your options.

Estimated Cost of Flecainide Medication

The cost of a 30-day supply of Flecainide without insurance can vary depending on the pharmacy and location. However, using a GoodRx coupon, the price typically ranges from $15 to $50 for a 30-day supply of Flecainide (100 mg tablets). Prices may fluctuate, so it’s a good idea to check with your pharmacy or use a coupon service like GoodRx to find the best price.

Possible Alternatives to Flecainide

If Flecainide is not suitable for you or if you’re exploring alternative treatments, several options are available depending on your condition. Always discuss any changes to your treatment plan with your healthcare provider, and feel free to schedule a telemedicine appointment with one of our providers to explore these alternatives.

  1. Atrial fibrillation: Alternatives include medications like Amiodarone, Sotalol, and Dronedarone. Lifestyle changes, such as reducing alcohol intake and managing stress, may also help.
  2. Atrial flutter: Treatment options may include catheter ablation or medications like Beta-blockers and Calcium channel blockers.
  3. Ventricular tachycardia: Amiodarone or Sotalol may be used as alternatives. Implantable cardioverter-defibrillators (ICDs) may also be considered for high-risk patients.
  4. Paroxysmal supraventricular tachycardia (PSVT): Vagal maneuvers, such as coughing or bearing down, may help. Medications like Beta-blockers or Calcium channel blockers can also be used.
  5. Wolff-Parkinson-White syndrome: Catheter ablation is often the treatment of choice. Medications like Amiodarone may also be considered.
  6. Premature ventricular contractions (PVCs): Beta-blockers or Calcium channel blockers may be alternatives. Reducing caffeine and stress can also help manage symptoms.
  7. Heart failure: Flecainide is generally not recommended for heart failure patients. Alternatives include medications like Beta-blockers, ACE inhibitors, and ARBs.
  8. Tachyarrhythmias: Beta-blockers or Calcium channel blockers may be used as alternatives. Catheter ablation may also be considered.
  9. Supraventricular arrhythmias: Beta-blockers, Calcium channel blockers, and catheter ablation are potential alternatives.
  10. Cardiac arrhythmias: Depending on the type of arrhythmia, alternatives may include Amiodarone, Sotalol, or catheter ablation.

Recent Updates on Flecainide Research

Recent research on Flecainide has focused on its safety and effectiveness in treating various arrhythmias. A 2022 study published in the Journal of Cardiovascular Electrophysiology found that Flecainide remains an effective option for patients with atrial fibrillation and other arrhythmias, particularly in those without structural heart disease. Ongoing research is also exploring the use of Flecainide in combination with other antiarrhythmic medications to improve outcomes and reduce side effects.

Additionally, there is growing interest in using Flecainide for genetic arrhythmias like Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT), with early studies showing promising results. However, more research is needed to fully understand its long-term effects in these populations.

As always, it’s important to stay informed about the latest research and discuss any new findings with your healthcare provider. If you have questions about Flecainide or its alternatives, our telemedicine providers are available to assist you.

James Kingsley
James Kingsley

Learn More
Scroll to Top